E A Yakovenko

ORCID: 0000-0001-7249-3332
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Attention Deficit Hyperactivity Disorder
  • Neurological Disorders and Treatments
  • Human Health and Disease
  • Child and Adolescent Psychosocial and Emotional Development
  • EEG and Brain-Computer Interfaces
  • Neural and Behavioral Psychology Studies
  • Functional Brain Connectivity Studies
  • Fibromyalgia and Chronic Fatigue Syndrome Research
  • Reading and Literacy Development
  • Autism Spectrum Disorder Research
  • Cognitive and developmental aspects of mathematical skills
  • Psychology of Development and Education
  • Infant Development and Preterm Care
  • Language Development and Disorders
  • Psychosomatic Disorders and Their Treatments
  • Psychological Treatments and Assessments
  • Migraine and Headache Studies
  • Pain Management and Placebo Effect
  • Children's Physical and Motor Development
  • Health, psychology, and well-being
  • Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Cardiovascular Syncope and Autonomic Disorders
  • Eating Disorders and Behaviors
  • Medical and Biological Sciences
  • Infant Health and Development

Institute of the Human Brain
2016-2025

Russian Academy of Sciences
2004-2017

University of Salzburg
2004

Objective. The aim of the study was to clarify clinical and psychological characteristics girls with ADHD at different age periods. Material methods. During screening study, outpatient records 1430 children were analyzed, among which two groups identified (872 aged 7—8 years, 558 adolescents 13—14 years). control group consisted 60 without psychoneurological pathology (30 years 30 following research methods used in work: SNAP-IY scale for assessing severity disease, Strengths Difficulties...

10.17116/jnevro202512501170 article EN S S Korsakov Journal of Neurology and Psychiatry 2025-02-11

Background.During the last three decades EEG-based biofeedback (neurofeedback) was used as an alternative treatment for reducing symptoms of ADHD.The goal this study to objectively assess efficacy training by comparing spectrograms, ERPs and ERDs, measured before after 20 sessions neurotherapy in a group ADHD children.Method.Electroencephalogram (EEG), Event related potentials (ERPs) event synchronisation/desynchronisation (ERD/ERS) were recorded computed auditory GO/ NOGO task 15-22 EEG...

10.1300/j184v11n02_02 article EN Journal of Neurotherapy 2007-07-23

To study clinical and pathophysiological symptoms of autonomic dysfunction syndrome in children adolescents assess the efficacy its treatment with nooclerin.Fifty-three patients, aged from 10 to 15 years, were examined. All patients underwent neurological examination, assessment A.M. Vein's questionnaire disorders, point Visual Analogous scale for headache fatigue, Spielberger-Khanin anxiety, Kerdo index, Hildebrandt's coefficient, electrocardiography clinoorthostatic test,...

10.17116/jnevro20181181143-49 article RU S S Korsakov Journal of Neurology and Psychiatry 2018-01-01

The article presents a review of scientific publications devoted to the study characteristics clinical picture and dynamics main symptoms in adult patients with attention deficit hyperactivity disorder (ADHD). authors present current data on prevalence this disease, leading manifestations most common comorbid pathology. Research impact ADHD adulthood educational professional activities are presented, economic criminological aspects considered. methods psychotherapeutic correction...

10.17116/jnevro202412402197 article EN S S Korsakov Journal of Neurology and Psychiatry 2024-01-01

To study impairments of cognitive control in patients with somatoform disorders (SD) and to evaluate the efficacy recognan treatment this pathology.Forty-six SD, aged from 18 45 years, were studied. A clinical history, neurological examination, assessment autonomic collected all patients. For objectification severity asthenic emotional disorders, Subjective Scale Asthenia (MFI-20), Hamilton Anxiety (HARS), Cognitive Emotion Regulation Questionnaire (CERQ used. quantitative impaired attention...

10.17116/jnevro201911904132 article RU S S Korsakov Journal of Neurology and Psychiatry 2019-01-01

To evaluate the efficacy of cytoflavin in treatment patients with burnout syndrome.Authors performed clinical, psychological and neurophysiological examinations 60 patients, aged 34-43 years. Results pharmacological therapy (30 patients) or ethylmethylhydroxypyridine succinate were compared. Control examination was conducted immediately after then 30 days to assess stability resulting effect.The higher (improvement 80% cases) as compared 70% identified. After treatment, improvement more...

10.17116/jnevro201511510166-70 article RU S S Korsakov Journal of Neurology and Psychiatry 2015-01-01

10.1007/s11055-021-01072-8 article EN Neuroscience and Behavioral Physiology 2021-03-01

To study the efficacy of cytoflavin in patients with somatoform disorders (SD).The included 60 SD, aged from 27 to 43 years. The was assessed by results psychological and neurophysiological examinations.The higher (the improvement patient's condition 63,3% cases) compared that ethylmethylhydroxypyridine succinate (56,7% found. Patient's state more stable after treatment cytoflavin.Цель исследования. Изучение эффективности применения препарата цитофлавин (таблетки, покрытые кишечнорастворимой...

10.17116/jnevro20171171121-24 article RU S S Korsakov Journal of Neurology and Psychiatry 2017-01-01

To evaluate the efficacy and safety of Сytoflavin in treatment cognitive emotional disorders patients with tension headache.Fifty headache, aged from 18 to 50 years, were studied. The following methods tests used: neurological examination, NPRS, STAI, CFQ, RAVLT, TOVA, electroencephalography (routine spectral analysis). treated Сytoflavin.After treatment, clinical improvement was observed 62.0% patients. A significant decrease trait anxiety inattention, as well an memory performance...

10.17116/jnevro201911911132 article RU S S Korsakov Journal of Neurology and Psychiatry 2019-01-01

<h3>ЦЕЛЬ ИССЛЕДОВАНИЯ</h3> Изучение эмоциональных и поведенческих расстройств у детей с нарушением развития речи. <h3>МАТЕРИАЛ И МЕТОДЫ</h3> В основноую группу были включены 60 диагнозом «специфическое расстройство экспрессивной речи» (CPPP) в возрасте 4—6 лет. Для оценки нарушений использованы опросник «Сильные стороны трудности» (Strengths and Difficulties Questionnaire), шкала SNAP-IV анкета Г.П. Лаврентьевой Т.М. Титаренко. объективизации степени выраженности речевых 10-балльные шкалы,...

10.17116/jnevro202112105157 article RU S S Korsakov Journal of Neurology and Psychiatry 2021-01-01

To study the impairment of cognitive functions in patients with different stages burnout syndrome (BS).78 aged 25-45 years (average age 36.9±9.5 years) were examined, which at BS stage divided into two subgroups: Residence (51.3%, n=40) and Exhaustion (48.7%, n=38). The control group consisted 106 practically healthy 36.3±7.2 following methods used: Russian-language version MBI questionnaire, questionnaire to diagnose level emotional by V.V. Boyko, CFQ, method «Learning 10 words» A.R. Luria,...

10.17116/jnevro2023123051139 article RU S S Korsakov Journal of Neurology and Psychiatry 2023-01-01

OBJECTIVE To study asthenic symptoms in patients with adjustment disorders and to assess the efficacy of cytoflavin their treatment. MATERIAL AND METHODS The included 100 patients, aged 20 43 years, a diagnosis disorder. Clinical, neurophysiological parametric methods were used. An state scale, Multidimensional Fatigue Inventory (MFI-20), digital rating scale (a 10-point variant) Headache Impact Test (HIT-6), Psychological Stress Measure (PSM-25), Cognitive Emotion Regulation Questionnaire,...

10.17116/jnevro202112107155 article EN S S Korsakov Journal of Neurology and Psychiatry 2021-01-01

Aim: to study clinical manifestation of neurasthenia in adolescents with school disadaptation and assess efficacy deanol aceglumate treatment this disorder. Patients methods: 64 aged from 14 17 years were included into the study. Control group consisted practically healthy adolescents. Diagnostic subjective scale for asthenia assessment (MFI-20), visual analogue manifestations (10-points scale), C. D. Spielberger’s state-trait anxiety test, vegetologic examination A. M. Vein’s questionnaire,...

10.15690/vsp.v12i5.806 article EN cc-by Вопросы современной педиатрии 2013-09-19

To qualify cognitive impairment in adults with attention deficit hyperactivity disorder (ADHD) and evaluate the efficacy of memoplant treatment this pathology.The authors present results clinical, psychological electroencephalographic examination 40 patients ADHD, aged from 18 to 45 years. All received dose 240 mg a day for 8 weeks.Adult ADHD were characterized by both subjective objective disorders memory attention. The study suggested dysfunction frontal-thalamic regulatory system lack...

10.17116/jnevro2017117519-13 article RU S S Korsakov Journal of Neurology and Psychiatry 2017-01-01

To evaluate clinical and neurophysiological changes in children with different variants of autism spectrum disorders during treatment cerebrolysin.Forty-three disorders, aged 4-6 years, were included the study. assess degree autism, quantitative scale assessing severity child CARS ('Childhood Autism Rating Scale') was used. A comparative analysis picture disease data electroencephalographic examination endogenous exogenous (organic) variant made.In lower scores autistic symptom on a greater...

10.17116/jnevro20171179171-75 article RU S S Korsakov Journal of Neurology and Psychiatry 2017-01-01

To study cognitive impairment in adults with attention deficit hyperactivity disorder (ADHD) and assess the efficacy of cerebrolysin treatment such patients.Thirty-eight patients ADHD, aged from 18 to 45 years were enrolled study. Along general neurological examination, several ADHA-specific scales tests (ASRS-V1-1, SFQ, BIS, Emotional Intelligence Self-Evaluation, TOVA) administered.There was a significant increase inattention impulsivity comparison control group, which can be regarded as...

10.17116/jnevro201811812131 article RU S S Korsakov Journal of Neurology and Psychiatry 2018-01-01

To study different forms of specific language impairment in children and to evaluate the efficacy cerebrolysin clinical electroencephalographic aspects.Authors examined 60 children, aged 5-7 years, with a (SLI).The showed significantly higher severity speech disorders, degree asthenia dyspraxia/dysgnosia group disorder receptive (SLI-R) compared expressive (SLI-E). A comparative analysis EEG power spectra large values slow theta-band SLI healthy children. Children SLI-R were characterized by...

10.17116/jnevro20151157198-102 article RU S S Korsakov Journal of Neurology and Psychiatry 2015-01-01

To determine clinical/neurophysiological characteristics of different forms attention deficit hyperactivity disorder (ADHD) and the efficacy treatment with cerebrolysin.Sixty children, aged 9 to 12 years, ADHD were examined using clinical electroencephalographic methods. Idiopathic residual-organic compared.The study shows significantly higher levels impulsivity in children form disease. There significant differences amplitude component engaging action (P3 Go) suppression NOGO) patients...

10.17116/jnevro2016116101117-121 article RU S S Korsakov Journal of Neurology and Psychiatry 2016-01-01

To study disorders of emotional regulation in different types attention deficit hyperactivity disorder (ADHD) children.58 children suffering from ADHD, aged 12 to 15 years were divided into 2 subgroups (38 with a combined form ADHD and 20 predominance inattention). The control group consisted 30 without manifestations neuropsychiatric disorders. following research methods used the work: SNAP-IY scale assess severity disease; Strengths Difficulties Questionnaire (SCT), for parents behavioral...

10.17116/jnevro2022122061100 article RU S S Korsakov Journal of Neurology and Psychiatry 2022-01-01

To study the clinical and neurophysiological features of children with low cognitive tempo (NCT), as well effectiveness drug Pantogam in treatment this pathology.

10.17116/jnevro2024124051120 article EN S S Korsakov Journal of Neurology and Psychiatry 2024-01-01
Coming Soon ...